StockCall Scrutinizes Warner Chilcott, Dynavax Technologies, Isis Pharma, and United Therapeutics

StockCall Scrutinizes Warner Chilcott, Dynavax Technologies, Isis Pharma, and
                             United Therapeutics

PR Newswire

LONDON, April 11, 2013

LONDON, April 11, 2013 /PRNewswire/ --

Markets continued their bullish streak for the week and created new highs.
Both S&P 500 and The Dow Jones Index closed at record highs of 1,587.73 and
14,802.24 respectively. The markets showed across the board gains with more
than 75 percent of the NASDAQ stocks increased their value during the session.
We followed the Healthcare sector, more precisely the Drug Manufacturers -
Other industry, by tracking major companies like Warner Chilcott Plc (NASDAQ:
WCRX), Dynavax Technologies Corporation (NASDAQ: DVAX), ISIS Pharmaceuticals
Inc. (NASDAQ: ISIS) and United Therapeutics Corporation (NASDAQ: UTHR).
StockCall reviewed the Drug Manufacturers - Other industry and chose WCRX,
DVAX, ISIS, and UTHR for its technical coverage. These free reports can be
seen for free at

Warner Chilcott Plc closed its latest trading session at $13.55, down 0.04
percent from its previous close. The stock traded in the range of $13.39 and
$13.77 in yesterday's session and traded 4.11 million shares. It is likely to
face its first resistance level at $13.98, and upon breaching this level the
stock may go up to $14.62. On the downside, Warner Chilcott may tumble to
$13.30 level. The stock is quite volatile as it sports a beta of 1.03. In
2013, it gained 15.91 percent whereas in the past 52 weeks, it lost 16.31
percent of its value. The stock is in a neutral mode. Download the free
research on WCRX by signing up now at

Dynavax Technologies Corporation's stock is down 13.69 percent on a YTD basis,
thanks to its 1.87 percent loss in the previous trading session. The stock
closed at $2.37 after trading in the range of $2.36 and $2.47. The stock shows
a bearish streak and may touch $2.34 level. Its second resistance level is at
$2.06. It traded 3.16 million shares during Wednesday's session, up from its
average trading volume of 2.78 million. Dynavax Technologies Corporation
declined 54.08 percent in the past 52 weeks but has shown some recovery in
2013. It is currently trading above its short-term moving average price of
$2.23. Register for today's free analysis on DVAX at

ISIS Pharmaceuticals Inc.'s stock remained in the green for its YTD returned
with 4.33 percent gain in Wednesday's trading session. The stock traded in the
range of $17.58 and $18.41 and closed at $18.30. However, it traded a
lower-than-average number of shares at 1.12 million. The stock is in a bullish
mode and is likely to maintain its upward ascent in the coming sessions. Its
first resistance level is at $18.77 and it may test the support level of
$18.00 in the coming trading sessions. ISIS Pharma is a fairly neutral stock
with its beta at 1.08. Free report on ISIS can be accessed by registering at

United Therapeutics Corporation traded in the range of $59.87 and $61.62 in
its latest trading session and ended the day at $61.26, up 2.72 percent. The
stock's 52 weeks range stands at $40.34 and $63.11. The company has gained
37.05 percent of its value in the past 12 months, while it grew 17.49 percent
on a YTD basis. United Therapeutics Corporation is in a bullish mode and may
find its first support level at $59.33. It is trading above its 20-day moving
average of $60.83, further confirming the bullish trend. United Therapeutics
commands market capitalization of $3.07 billion. Register with StockCall and
download the research on UTHR for free at

About is a financial website where investors can have easy, precise
and comprehensive research and opinions on stocks making the headlines. Sign
up today to talk to our financial analyst at


Contact: William T. Knight, Email:, Contact Number:
+1(646)396-9857 (9:00 am EST - 01:30 pm EST)
Press spacebar to pause and continue. Press esc to stop.